← Back to Search

Robotic vs. Video-Assisted Thoracic Surgery for Early Stage Lung Cancer

N/A
Recruiting
Led By Waël C Hanna, MDCM, MBA, FRCSC
Research Sponsored by St. Joseph's Healthcare Hamilton
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >/= 18 years
Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
Must not have
Not a candidate for minimally invasive surgery.
Clinical stage IIIb or IV NSCLC
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years post-surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial will help determine if robotic technology is better than traditional methods for early stage lung cancer surgery.

Who is the study for?
This trial is for adults over 18 with early-stage lung cancer (stage I, II or IIIa) who are candidates for minimally invasive lung surgery. It's not suitable for those with more advanced stage IIIb or IV cancer, or those who can't have minimally invasive procedures.
What is being tested?
The study compares two types of minimally invasive lung surgery: video-assisted thoracoscopic lobectomy (VATS) and robotic thoracic surgery (RTS). Patients will be randomly assigned to receive either VATS, which uses a camera and small incisions, or RTS, which employs precise instruments and 3D imaging.
What are the potential side effects?
While the trial description does not specify side effects, both surgical methods may include risks such as bleeding, infection at the incision site, pain after operation, prolonged air leak from lungs or general complications related to surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My lung cancer is at an early to mid-stage (I, II, or IIIa).

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot have surgery with small incisions.
Select...
My lung cancer is in an advanced stage.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years post-surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Difference in HRQOL scores at week 12 between the treatment groups
Secondary study objectives
Cost Effectiveness
Difference in 5-year survival rate between the two groups
Difference in HRQOL scores between the treatment groups
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Thoracoscopic LobectomyActive Control1 Intervention
Group II: Robotic LobectomyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor
201 Previous Clinical Trials
26,361 Total Patients Enrolled
1 Trials studying Thoracic Surgery
University of Toronto / Toronto General HospitalUNKNOWN
University of FloridaOTHER
1,402 Previous Clinical Trials
764,174 Total Patients Enrolled

Media Library

Robotic thoracic surgery Clinical Trial Eligibility Overview. Trial Name: NCT02617186 — N/A
Thoracic Surgery Research Study Groups: Thoracoscopic Lobectomy, Robotic Lobectomy
Thoracic Surgery Clinical Trial 2023: Robotic thoracic surgery Highlights & Side Effects. Trial Name: NCT02617186 — N/A
Robotic thoracic surgery 2023 Treatment Timeline for Medical Study. Trial Name: NCT02617186 — N/A
~60 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top